0 mg

DRUG2 trials

Sponsors

Universitair Medisch Centrum Groningen, Universitair Medisch Centrum Groningen, Universitair Medisch Centrum Utrecht

Conditions

COVID-19Herpes ZosterPsoriatic arthritisimpaired immunitykidney transplantation

Phase 3

Prospective Randomized trial of Everolimus replacing MMF/MP Acid by the RECOVAC consortium to increase VACcine response in kidney transplant patients

CompletedCTIS2023-503894-39-00

Universitair Medisch Centrum Groningen, Universitair Medisch Centrum GroningenCOVID-19, Herpes Zoster, impaired immunity +1

Start: 2023-08-22End: 2024-02-27Target: 110Updated: 2023-10-10

Phase 4

A stratification trial to determine key immunological factors predicting Tofacitinib efficacy in Psoriatic Arthritis (PsA); TOFA-PREDICT

CompletedCTIS2024-510903-12-00

Universitair Medisch Centrum UtrechtPsoriatic arthritis

End: 2025-12-08Target: 160Updated: 2024-09-06